<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38469363</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2699-4445</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Free neuropathology</Title><ISOAbbreviation>Free Neuropathol</ISOAbbreviation></Journal><ArticleTitle>HIV and COVID-19: two pandemics with significant (but different) central nervous system complications.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.17879/freeneuropathology-2024-5343</ELocationID><Abstract><AbstractText>Human immunodeficiency virus (HIV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cause significant neurologic disease. Central nervous system (CNS) involvement of HIV has been extensively studied, with well-documented invasion of HIV into the brain in the initial stage of infection, while the acute effects of SARS-CoV-2 in the brain are unclear. Neuropathologic features of active HIV infection in the brain are well characterized whereas neuropathologic findings in acute COVID-19 are largely non-specific. On the other hand, neuropathologic substrates of chronic dysfunction in both infections, as HIV-associated neurocognitive disorders (HAND) and post-COVID conditions (PCC)/long COVID are unknown. Thus far, neuropathologic studies on patients with HAND in the era of combined antiretroviral therapy have been inconclusive, and autopsy studies on patients diagnosed with PCC have yet to be published. Further longitudinal, multidisciplinary studies on patients with HAND and PCC and neuropathologic studies in comparison to controls are warranted to help elucidate the mechanisms of CNS dysfunction in both conditions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Magaki</LastName><ForeName>Shino</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Section of Neuropathology, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Section of Neuropathology, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Karam</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Section of Neuropathology, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hilda</LastName><ForeName>Mirbaha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Section of Neuropathology, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yong</LastName><ForeName>William H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of California-Irvine School of Medicine, Irvine, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Achim</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of California San Diego, La Jolla, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fishbein</LastName><ForeName>Gregory</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fishbein</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garner</LastName><ForeName>Omai</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salamon</LastName><ForeName>Noriko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Christopher K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Section of Neuropathology, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdes-Sueiras</LastName><ForeName>Miguel A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Jeffrey J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Division of Cardiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelesidis</LastName><ForeName>Theodoros</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathisen</LastName><ForeName>Glenn E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Olive View-University of California Los Angeles Medical Center, Sylmar, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavretsky</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singer</LastName><ForeName>Elyse J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinters</LastName><ForeName>Harry V</ForeName><Initials>HV</Initials><AffiliationInfo><Affiliation>Section of Neuropathology, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Research Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG059502</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 MH100929</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Free Neuropathol</MedlineTA><NlmUniqueID>101768755</NlmUniqueID><ISSNLinking>2699-4445</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">HIV-associated neurocognitive disorders</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Neuropathology</Keyword><Keyword MajorTopicYN="N">Post-COVID conditions</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>12</Day><Hour>3</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38469363</ArticleId><ArticleId IdType="pmc">PMC10925920</ArticleId><ArticleId IdType="doi">10.17879/freeneuropathology-2024-5343</ArticleId><ArticleId IdType="pii">5-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ruelas DS, Greene WC. An integrated overview of HIV-1 latency. Cell 2013;155:519&#x2013;29. 10.1016/j.cell.2013.09.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.09.044</ArticleId><ArticleId IdType="pmc">PMC4361081</ArticleId><ArticleId IdType="pubmed">24243012</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981;305:1425&#x2013;31. 10.1056/NEJM198112103052401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198112103052401</ArticleId><ArticleId IdType="pubmed">6272109</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene WC. A history of AIDS: Looking back to see ahead. Eur J Immunol 2007;37:94&#x2013;102. 10.1002/eji.200737441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200737441</ArticleId><ArticleId IdType="pubmed">17972351</ArticleId></ArticleIdList></Reference><Reference><Citation>Barr&#xe9;-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868&#x2013;71. 10.1126/science.6189183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6189183</ArticleId><ArticleId IdType="pubmed">6189183</ArticleId></ArticleIdList></Reference><Reference><Citation>Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984;224:497&#x2013;500. 10.1126/science.6200935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6200935</ArticleId><ArticleId IdType="pubmed">6200935</ArticleId></ArticleIdList></Reference><Reference><Citation>Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, et al. HIV-associated neurocognitive disorder &#x2014; pathogenesis and prospects for treatment. Nat Rev Neurol 2016;12:234&#x2013;48. 10.1038/nrneurol.2016.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.27</ArticleId><ArticleId IdType="pmc">PMC4937456</ArticleId><ArticleId IdType="pubmed">26965674</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaravilli F, Bazille C, Gray F. Neuropathologic contributions to understanding AIDS and the central nervous system. Brain Pathol 2007;17:197&#x2013;208. 10.1111/j.1750-3639.2007.00047.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2007.00047.x</ArticleId><ArticleId IdType="pmc">PMC8095617</ArticleId><ArticleId IdType="pubmed">17388950</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavel F, Gu&#xe9;tard D, Brun-V&#xe9;zinet F, Chamaret S, Rey MA, Santos-Ferreira MO, et al. Isolation of a new human retrovirus from West African patients with AIDS. Science 1986;233:343&#x2013;6. 10.1126/science.2425430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2425430</ArticleId><ArticleId IdType="pubmed">2425430</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavel F, Mansinho K, Chamaret S, Guetard D, Favier V, Nina J, et al. Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med 1987;316:1180&#x2013;5. 10.1056/NEJM198705073161903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198705073161903</ArticleId><ArticleId IdType="pubmed">3472076</ArticleId></ArticleIdList></Reference><Reference><Citation>Trickey A, May MT, Vehreschild J-J, Obel N, Gill MJ, Crane HM, et al. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV 2017;4:e349&#x2013;56. 10.1016/S2352-3018(17)30066-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3018(17)30066-8</ArticleId><ArticleId IdType="pmc">PMC5555438</ArticleId><ArticleId IdType="pubmed">28501495</ArticleId></ArticleIdList></Reference><Reference><Citation>Joint United Nations Programme on HIV/AIDS. UNAIDS Data 2022. https://www.unaids.org/sites/default/files/media_asset/data-book-2022_en.pdf. Accessed: June 28, 2023.</Citation></Reference><Reference><Citation>Bissel SJ, Wiley CA. Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations. Brain Pathol 2004;14:97&#x2013;108. 10.1111/j.1750-3639.2004.tb00503.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2004.tb00503.x</ArticleId><ArticleId IdType="pmc">PMC1449744</ArticleId><ArticleId IdType="pubmed">14997942</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrick MK, Johnston JB, Power C. Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility. J Virol 2002;76:7923&#x2013;31. 10.1128/jvi.76.16.7923-7931.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.76.16.7923-7931.2002</ArticleId><ArticleId IdType="pmc">PMC155171</ArticleId><ArticleId IdType="pubmed">12133996</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson M. HIV-1 pathogenesis. Nat Med 2003;9:853&#x2013;60. 10.1038/nm0703-853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0703-853</ArticleId><ArticleId IdType="pubmed">12835705</ArticleId></ArticleIdList></Reference><Reference><Citation>Albright A V., Shieh JTC, Itoh T, Lee B, Pleasure D, O&#x2019;Connor MJ, et al. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J Virol 1999;73:205&#x2013;13. 10.1128/jvi.73.1.205-213.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.73.1.205-213.1999</ArticleId><ArticleId IdType="pmc">PMC103824</ArticleId><ArticleId IdType="pubmed">9847323</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Scarano F, Mart&#xed;n-Garc&#xed;a J. The neuropathogenesis of AIDS. Nat Rev Immunol 2005;5:69&#x2013;81. 10.1038/nri1527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1527</ArticleId><ArticleId IdType="pubmed">15630430</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito Y, Sharer LR, Epstein LG, Michaels J, Mintz M, Louder M, et al. Overexpression of nef as a marker for restricted HIV&#x2010;1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994;44:474&#x2013;474. 10.1212/WNL.44.3_PART_1.474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.44.3_PART_1.474</ArticleId><ArticleId IdType="pubmed">8145918</ArticleId></ArticleIdList></Reference><Reference><Citation>An SF, Groves M, Giometto B, Beckett AAJ, Scaravilli F. Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/in situ hybridisation technique. Acta Neuropathol 1999;98:481&#x2013;7. 10.1007/s004010051113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010051113</ArticleId><ArticleId IdType="pubmed">10541871</ArticleId></ArticleIdList></Reference><Reference><Citation>Resnick L, Berger JR, Shapshak P, Tourtellotte WW. Early penetration of the blood-brain-barrier by HIV. Neurology 1988;38:9&#x2013;14. 10.1212/WNL.38.1.9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.38.1.9</ArticleId><ArticleId IdType="pubmed">3422110</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray F, Scaravilli F, Everall I, Chretien F, An S, Boche D, et al. Neuropathology of early HIV-1 infection. Brain Pathol 1996;6:1&#x2013;15. 10.1111/j.1750-3639.1996.tb00775.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.1996.tb00775.x</ArticleId><ArticleId IdType="pubmed">8866743</ArticleId></ArticleIdList></Reference><Reference><Citation>Valcour V, Sithinamsuwan P, Letendre S, Ances B. Pathogenesis of HIV in the central nervous system. Curr HIV/AIDS Rep 2011;8:54&#x2013;61. 10.1007/s11904-010-0070-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11904-010-0070-4</ArticleId><ArticleId IdType="pmc">PMC3035797</ArticleId><ArticleId IdType="pubmed">21191673</ArticleId></ArticleIdList></Reference><Reference><Citation>Clifford DB. HIV-associated neurocognitive disorder. Curr Opin Infect Dis 2017;30:117&#x2013;22. 10.1097/QCO.0000000000000328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000328</ArticleId><ArticleId IdType="pmc">PMC5382956</ArticleId><ArticleId IdType="pubmed">27798498</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan IL, Smith BR, von Geldern G, Mateen FJ, McArthur JC. HIV-associated opportunistic infections of the CNS. Lancet Neurol 2012;11:605&#x2013;17. 10.1016/S1474-4422(12)70098-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70098-4</ArticleId><ArticleId IdType="pubmed">22710754</ArticleId></ArticleIdList></Reference><Reference><Citation>Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neuro cognitive disorders. Neurology 2007;69:1789&#x2013;99. 10.1212/01.WNL.0000287431.88658.8b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000287431.88658.8b</ArticleId><ArticleId IdType="pmc">PMC4472366</ArticleId><ArticleId IdType="pubmed">17914061</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen RS, Cornblath DR, Epstein LG, Foa RP, McArthur JC, Price RW, et al. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 1991;41:778&#x2013;85. 10.1212/wnl.41.6.778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.41.6.778</ArticleId><ArticleId IdType="pubmed">2046917</ArticleId></ArticleIdList></Reference><Reference><Citation>Navia BA, Cho BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986;19:517&#x2013;24. 10.1002/ana.410190603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410190603</ArticleId><ArticleId IdType="pubmed">3729308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho DD, Bredesen DE, Vinters HV, Daar ES. The acquired immunodeficiency syndrome (AIDS) dementia complex. Ann Intern Med 1989;111:400&#x2013;10. 10.7326/0003-4819-111-5-400.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-111-5-400</ArticleId><ArticleId IdType="pubmed">2548429</ArticleId></ArticleIdList></Reference><Reference><Citation>Budka H, Wiley CA, Kleihues P, Artigas J, Asbury AK, Cho ES, et al. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1991;1:143&#x2013;52. 10.1111/j.1750-3639.1991.tb00653.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.1991.tb00653.x</ArticleId><ArticleId IdType="pubmed">1669703</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, et al. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology 2016;86:334&#x2013;40. 10.1212/WNL.0000000000002277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002277</ArticleId><ArticleId IdType="pmc">PMC4776086</ArticleId><ArticleId IdType="pubmed">26718568</ArticleId></ArticleIdList></Reference><Reference><Citation>Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infect Dis 2013;13:976&#x2013;86. 10.1016/S1473-3099(13)70269-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70269-X</ArticleId><ArticleId IdType="pmc">PMC4108270</ArticleId><ArticleId IdType="pubmed">24156898</ArticleId></ArticleIdList></Reference><Reference><Citation>Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology 2010;75:2087&#x2013;96. 10.1212/WNL.0b013e318200d727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318200d727</ArticleId><ArticleId IdType="pmc">PMC2995535</ArticleId><ArticleId IdType="pubmed">21135382</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacktor N. Changing clinical phenotypes of HIV-associated neurocognitive disorders. J Neurovirol 2018;24:141&#x2013;5. 10.1007/s13365-017-0556-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-017-0556-6</ArticleId><ArticleId IdType="pmc">PMC5787044</ArticleId><ArticleId IdType="pubmed">28752495</ArticleId></ArticleIdList></Reference><Reference><Citation>Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, LeBlanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. J Neurovirol 2011;17:3&#x2013;16. 10.1007/s13365-010-0006-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-010-0006-1</ArticleId><ArticleId IdType="pmc">PMC3032197</ArticleId><ArticleId IdType="pubmed">21174240</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacktor N, Robertson K. Evolving clinical phenotypes in HIV-associated neurocognitive disorders. Curr Opin HIV AIDS 2014;9:517&#x2013;20. 10.1097/COH.0000000000000102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/COH.0000000000000102</ArticleId><ArticleId IdType="pmc">PMC4212639</ArticleId><ArticleId IdType="pubmed">25203640</ArticleId></ArticleIdList></Reference><Reference><Citation>Smail RC, Brew BJ. HIV-associated neurocognitive disorder. Handb Clin Neurol 2018;152:75-97. 10.1016/B978-0-444-63849-6.00007-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63849-6.00007-4</ArticleId><ArticleId IdType="pubmed">29604986</ArticleId></ArticleIdList></Reference><Reference><Citation>Cysique LA, Maruff P, Brew BJ. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J Neurovirol 2004;10:350&#x2013;7. 10.1080/13550280490521078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280490521078</ArticleId><ArticleId IdType="pubmed">15765806</ArticleId></ArticleIdList></Reference><Reference><Citation>Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O, et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 cohort. Neurology 2004;63:822&#x2013;7. 10.1212/01.WNL.0000134665.58343.8D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000134665.58343.8D</ArticleId><ArticleId IdType="pmc">PMC1382180</ArticleId><ArticleId IdType="pubmed">15365130</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker JT, Kingsley L, Mullen J, Cohen B, Martin E, Miller EN, et al. Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology 2009;73:1292&#x2013;9. 10.1212/WNL.0b013e3181bd10e7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bd10e7</ArticleId><ArticleId IdType="pmc">PMC2764414</ArticleId><ArticleId IdType="pubmed">19841381</ArticleId></ArticleIdList></Reference><Reference><Citation>McCutchan JA, Marquie-Beck JA, FitzSimons CA, Letendre SL, Ellis RJ, Heaton RK, et al. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology 2012;78:485&#x2013;92. 10.1212/WNL.0b013e3182478d64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182478d64</ArticleId><ArticleId IdType="pmc">PMC3280051</ArticleId><ArticleId IdType="pubmed">22330412</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaskaran K, Mussini C, Antinori A, Walker AS, Dorrucci M, Sabin C, et al. Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol 2008;63:213&#x2013;21. 10.1002/ana.21225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21225</ArticleId><ArticleId IdType="pubmed">17894380</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, et al. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS 2011;25:1747&#x2013;51. 10.1097/QAD.0b013e32834a40cd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0b013e32834a40cd</ArticleId><ArticleId IdType="pmc">PMC3867631</ArticleId><ArticleId IdType="pubmed">21750419</ArticleId></ArticleIdList></Reference><Reference><Citation>Valcour VG, Ananworanich J, Agsalda M, Sailasuta N, Chalermchai T, Schuetz A, et al. HIV DNA reservoir increases risk for cognitive disorders in cART-na&#xef;ve patients. PLoS One 2013;8:e70164. 10.1371/journal.pone.0070164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0070164</ArticleId><ArticleId IdType="pmc">PMC3729685</ArticleId><ArticleId IdType="pubmed">23936155</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson KR, Robertson WT, Ford S, Watson D, Fiscus S, Harp AG, et al. Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr 2004;36:562&#x2013;6. 10.1097/00126334-200405010-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00126334-200405010-00003</ArticleId><ArticleId IdType="pubmed">15097298</ArticleId></ArticleIdList></Reference><Reference><Citation>Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003;17:1539&#x2013;45. 10.1097/00002030-200307040-00015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002030-200307040-00015</ArticleId><ArticleId IdType="pubmed">12824792</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevigny JJ, Albert SM, McDermott MP, Schifitto G, McArthur JC, Sacktor N, et al. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol 2007;64:97&#x2013;102. 10.1001/archneur.64.1.97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.64.1.97</ArticleId><ArticleId IdType="pubmed">17210815</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivithanaporn P, Heo G, Gamble J, Krentz HB, Hoke A, Gill MJ, et al. Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology 2010;75:1150&#x2013;8. 10.1212/WNL.0b013e3181f4d5bb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181f4d5bb</ArticleId><ArticleId IdType="pmc">PMC3013488</ArticleId><ArticleId IdType="pubmed">20739646</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal J, Tyor W. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders. J Neurovirol 2019;25:673&#x2013;85. 10.1007/s13365-019-00735-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-019-00735-0</ArticleId><ArticleId IdType="pmc">PMC7212499</ArticleId><ArticleId IdType="pubmed">30868422</ArticleId></ArticleIdList></Reference><Reference><Citation>Heaton RK, Ellis RJ, Tang B, Marra CM, Rubin LH, Clifford DB, et al. Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER study. Brain 2023;146:1121&#x2013;31. 10.1093/brain/awac465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac465</ArticleId><ArticleId IdType="pmc">PMC10169412</ArticleId><ArticleId IdType="pubmed">36477867</ArticleId></ArticleIdList></Reference><Reference><Citation>Stout JC, Ellis RJ, Jernigan TL, Archibald SL, Abramson I, Wolfson T, et al. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. Arch Neurol 1998;55:161&#x2013;8. 10.1001/archneur.55.2.161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.55.2.161</ArticleId><ArticleId IdType="pubmed">9482357</ArticleId></ArticleIdList></Reference><Reference><Citation>Jernigan TL, Grant I, Hesselink JR, Atkinson JH, Velin RA, McCutchan JA, et al. Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. Arch Neurol 1993;50:250&#x2013;5. 10.1001/archneur.1993.00540030016007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1993.00540030016007</ArticleId><ArticleId IdType="pubmed">8442702</ArticleId></ArticleIdList></Reference><Reference><Citation>Heindel WC, Jernigan TL, Archibald SL, Achim CL, Masliah E, Wiley CA. The relationship of quantitative brain magnetic resonance imaging measures to neuropathologic indexes of human immunodeficiency virus infection. Arch Neurol 1994;51:1129&#x2013;35. 10.1001/archneur.1994.00540230067015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1994.00540230067015</ArticleId><ArticleId IdType="pubmed">7980109</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardenas V, Meyerhoff D, Studholme C, Kornak J, Rothlind J, Lampiris H, et al. Evidence for ongoing brain injury in human immunodeficiency viruspositive patients treated with antiretroviral therapy. J Neurovirol 2009;15:324&#x2013;33. 10.1080/13550280902973960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280902973960</ArticleId><ArticleId IdType="pmc">PMC2889153</ArticleId><ArticleId IdType="pubmed">19499454</ArticleId></ArticleIdList></Reference><Reference><Citation>Alakkas A, Ellis RJ, Watson CW-M, Umlauf A, Heaton RK, Letendre S, et al. White matter damage, neuroinflammation, and neuronal integrity in HAND. J Neurovirol 2019;25:32&#x2013;41. 10.1007/s13365-018-0682-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-018-0682-9</ArticleId><ArticleId IdType="pmc">PMC6416232</ArticleId><ArticleId IdType="pubmed">30291567</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaganti J, Marripudi K, Staub LP, Rae CD, Gates TM, Moffat KJ, et al. Imaging correlates of the blood-brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications. AIDS 2019;33:1843&#x2013;52. 10.1097/QAD.0000000000002300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000002300</ArticleId><ArticleId IdType="pubmed">31274535</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell JE. An update on the neuropathology of HIV in the HAART era. Histopathology 2004;45:549&#x2013;59. 10.1111/j.1365-2559.2004.02004.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2559.2004.02004.x</ArticleId><ArticleId IdType="pubmed">15569045</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgello S. HIV neuropathology. Handb Clin Neurol 2018;152:3&#x2013;19. 10.1016/B978-0-444-63849-6.00002-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63849-6.00002-5</ArticleId><ArticleId IdType="pubmed">29604982</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw GM, Harper ME, Hahn BH, Epstein LG, Gajdusek DC, Price RW, et al. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 1985;227:177&#x2013;82. 10.1126/science.298142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.298142</ArticleId><ArticleId IdType="pubmed">2981429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho DD, Sarngadharan MG, Resnick L, Dimarzoveronese F, Rota TR, Hirsch MS. Primary human T-lymphotropic virus type III infection. Ann Intern Med 1985;103:880&#x2013;3. 10.7326/0003-4819-103-6-880.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-103-6-880</ArticleId><ArticleId IdType="pubmed">2998251</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy JA, Shimabukuro J, Hollander H, Mills J, Kaminsky L. Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet 1985;2:585&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">2863599</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray F, Chr&#xe9;tien F, Vallat-Decouvelaere AV, Scaravilli F. The changing pattern of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol 2003;62:429&#x2013;40. 10.1093/jnen/62.5.429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/62.5.429</ArticleId><ArticleId IdType="pubmed">12769183</ArticleId></ArticleIdList></Reference><Reference><Citation>Elovaara I, Sepp&#xe4;l&#xe4; I, Poutiainen E, Suni J, Valle SL. Intrathecal humoral immunologic response in neurologically symptomatic and asymptomatic patients with human immunodeficiency virus infection. Neurology 1988;38:1451&#x2013;6. 10.1212/WNL.38.9.1451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.38.9.1451</ArticleId><ArticleId IdType="pubmed">3166115</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992;42:1736&#x2013;9. 10.1212/wnl.42.9.1736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.42.9.1736</ArticleId><ArticleId IdType="pubmed">1513462</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase AT. Pathogenesis of lentivirus infections. Nature 1986;322:130&#x2013;6. 10.1038/322130a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/322130a0</ArticleId><ArticleId IdType="pubmed">2425264</ArticleId></ArticleIdList></Reference><Reference><Citation>Petito CK, Cash KS. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 1992;32:658&#x2013;66. 10.1002/ana.410320509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410320509</ArticleId><ArticleId IdType="pubmed">1449246</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A 1986;83:7089&#x2013;93. 10.1073/pnas.83.18.7089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.83.18.7089</ArticleId><ArticleId IdType="pmc">PMC386658</ArticleId><ArticleId IdType="pubmed">3018755</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiley CA, Achim CL, Christopherson C, Kidane Y, Kwok S, Masliah E, Mellors J, Radhakrishnan L, Wang G, Soontornniyomkij V. HIV mediates a productive infection of the brain. AIDS 1999;13:2055&#x2013;9. 10.1097/00002030-199910220-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002030-199910220-00007</ArticleId><ArticleId IdType="pubmed">10546857</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenig S, Gendelman HE, Orenstein JM, Canto MC, Pezeshkpour H, Yungbluth M, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089&#x2013;98. 10.1126/science.3016903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3016903</ArticleId><ArticleId IdType="pubmed">3016903</ArticleId></ArticleIdList></Reference><Reference><Citation>Navia BA, Cho ES, Petito CK PR. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986;19:525&#x2013;35. 10.1002/ana.410190603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410190603</ArticleId><ArticleId IdType="pubmed">3014994</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosenza MA, Zhao ML, Si Q, Lee SC. Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol 2003;12:442&#x2013;55. 10.1111/j.1750-3639.2002.tb00461.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2002.tb00461.x</ArticleId><ArticleId IdType="pmc">PMC8095974</ArticleId><ArticleId IdType="pubmed">12408230</ArticleId></ArticleIdList></Reference><Reference><Citation>Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ, et al. Extensive astrocyte infection is prominent in human immunodeficiency virus - associated dementia. Ann Neurol 2009;66:253&#x2013;8. 10.1002/ana.21697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21697</ArticleId><ArticleId IdType="pubmed">19743454</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KA, Cherry CL, Bell JE, McLean CA. Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals. Am J Pathol 2011;179:1623&#x2013;9. 10.1016/j.ajpath.2011.06.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2011.06.039</ArticleId><ArticleId IdType="pmc">PMC3181362</ArticleId><ArticleId IdType="pubmed">21871429</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray F, Lescs MC, Keohane C, Paraire F, Marc B, Durigon M, et al. Early brain changes in HIV infection: neuropathological study of 11 HIV seropositive, non-AIDS cases. J Neuropathol Exp Neurol 1992;51:177&#x2013;85. 10.1097/00005072-199203000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199203000-00007</ArticleId><ArticleId IdType="pubmed">1538241</ArticleId></ArticleIdList></Reference><Reference><Citation>An SF, Ciardi A, Giometto B, Scaravilli T, Gray F, Scaravilli F. Investigation on the expression of major histocompatibility complex class II and cytokines and detection of HIV-1 DNA within brains of asymptomatic and symptomatic HIV-1-positive patients. Acta Neuropathol 1996;91:494&#x2013;503. 10.1007/s004010050457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010050457</ArticleId><ArticleId IdType="pubmed">8740230</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders KH, Guerra WF, Tomiyasu U, Verity MA, Vinters HV. The neuropathology of AIDS. UCLA experience and review. Am J Pathol 1986;124:537&#x2013;58. .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1888341</ArticleId><ArticleId IdType="pubmed">2876640</ArticleId></ArticleIdList></Reference><Reference><Citation>Vago L, Trabattoni G, Lechi A, Cristina S, Budka H. Neuropathology of AIDS dementia. A review after 205 post mortem examinations. Acta Neurol (Napoli). 1990 Feb;12:32-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">2336992</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh K, Thompson W, Megyesi J, Wiley CA, Hammond R. HIV-1/AIDS neuropathology in a Canadian teaching centre. Can J Neurol Sci 2004;31:235&#x2013;41. 10.1017/S0317167100053889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0317167100053889</ArticleId><ArticleId IdType="pubmed">15198450</ArticleId></ArticleIdList></Reference><Reference><Citation>Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 1983;14:403&#x2013;18. 10.1002/ana.410140404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410140404</ArticleId><ArticleId IdType="pubmed">6314874</ArticleId></ArticleIdList></Reference><Reference><Citation>Budka H, Costanzi G, Cristina S, Lechi A, Parravicini C, Trabattoni R, et al. Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol 1987;75:185&#x2013;98. 10.1007/bf00687080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf00687080</ArticleId><ArticleId IdType="pubmed">3434225</ArticleId></ArticleIdList></Reference><Reference><Citation>Budka H. Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS). Acta Neuropathol 1986;69:253&#x2013;8. 10.1007/BF00688301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00688301</ArticleId><ArticleId IdType="pubmed">3962603</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharer LR, Cho ES, Epstein LG. Multinucleated giant cells and HTLV-III in AIDS encephalopathy. Hum Pathol 1985;16:760. 10.1016/S0046-8177(85)80245-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0046-8177(85)80245-8</ArticleId><ArticleId IdType="pubmed">2991110</ArticleId></ArticleIdList></Reference><Reference><Citation>Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HIV&#x2010;1 brain infection: clinical&#x2010;virological correlations. Ann Neurol 1995;38:563&#x2013;70. 10.1002/ana.410380404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410380404</ArticleId><ArticleId IdType="pubmed">7574452</ArticleId></ArticleIdList></Reference><Reference><Citation>Shieh JT, Mart&#xed;n J, Baltuch G, Malim MH, Gonz&#xe1;lez-Scarano F. Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains. J Virol 2000;74:693&#x2013;701. 10.1128/jvi.74.2.693-701.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.2.693-701.2000</ArticleId><ArticleId IdType="pmc">PMC111589</ArticleId><ArticleId IdType="pubmed">10623731</ArticleId></ArticleIdList></Reference><Reference><Citation>Budka H. Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991;1:163&#x2013;75. 10.1111/j.1750-3639.1991.tb00656.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.1991.tb00656.x</ArticleId><ArticleId IdType="pubmed">1669705</ArticleId></ArticleIdList></Reference><Reference><Citation>Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol 2009;15:360&#x2013;70. 10.3109/13550280903131915.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13550280903131915</ArticleId><ArticleId IdType="pmc">PMC3078805</ArticleId><ArticleId IdType="pubmed">20175693</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford TD, Letendre SL, Larrea GJ, Masliah E. Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol 2003;13:195&#x2013;210. 10.1111/j.1750-3639.2003.tb00019.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2003.tb00019.x</ArticleId><ArticleId IdType="pmc">PMC4842209</ArticleId><ArticleId IdType="pubmed">12744473</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah E, DeTeresa RM, Mallory ME, Hansen LA. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 2000;14:69&#x2013;74. 10.1097/00002030-200001070-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002030-200001070-00008</ArticleId><ArticleId IdType="pubmed">10714569</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgello S, Mahboob R, Yakoushina T, Khan S, Hague K. Autopsy findings in a human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors, and time. Arch Pathol Lab Med 2002;126:182&#x2013;90. 10.5858/2002-126-0182-AFIAHI.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/2002-126-0182-AFIAHI</ArticleId><ArticleId IdType="pubmed">11825115</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelman BB, Lisinicchia JG, Morgello S, Masliah E, Commins D, Achim CL, et al. Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. J Acquir Immune Defic Syndr 2013;62:487&#x2013;95. 10.1097/QAI.0b013e31827f1bdb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0b013e31827f1bdb</ArticleId><ArticleId IdType="pmc">PMC3664102</ArticleId><ArticleId IdType="pubmed">23242157</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellinger KA, Setinek U, Drlicek M, B&#xf6;hm G, Steurer A, Lintner F. Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol 2000;100:213&#x2013;20. 10.1007/s004010000245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010000245</ArticleId><ArticleId IdType="pubmed">10963370</ArticleId></ArticleIdList></Reference><Reference><Citation>Umlauf A, Soontornniyomkij B, Sundermann EE, Gouaux B, Ellis RJ, Levine AJ, et al. Risk of developing cerebral &#x3b2;-amyloid plaques with posttranslational modification among HIV-infected adults. AIDS 2019;33:2157&#x2013;66. 10.1097/QAD.0000000000002336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000002336</ArticleId><ArticleId IdType="pmc">PMC6852888</ArticleId><ArticleId IdType="pubmed">31688040</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray F, Keohane C. The neuropathology of HIV infection in the era of highly active antiretroviral therapy (HAART). Brain Pathol 2003;13:79&#x2013;83. 10.1111/j.1750-3639.2003.tb00008.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2003.tb00008.x</ArticleId><ArticleId IdType="pmc">PMC8095826</ArticleId><ArticleId IdType="pubmed">12580547</ArticleId></ArticleIdList></Reference><Reference><Citation>Vago L, Bonetto S, Nebuloni M, Duca P, Carsana L, Zerbi P, et al. Pathological findings in the central nervous system of AIDS patients on assumed antiretroviral therapeutic regimens: retrospective study of 1597 autopsies. AIDS 2002;16:1925&#x2013;8. 10.1097/00002030-200209270-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002030-200209270-00009</ArticleId><ArticleId IdType="pubmed">12351952</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiley CA, Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 1994;36:673&#x2013;6. 10.1002/ana.410360422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410360422</ArticleId><ArticleId IdType="pubmed">7944304</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995;38:755&#x2013;62. 10.1002/ana.410380510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410380510</ArticleId><ArticleId IdType="pubmed">7486867</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray F, Haug H, Chimelli L, Geny C, Gaston A, Scaravilli F, et al. Prominent cortical atrophy with neuronal loss as correlate of human immunodeficiency virus encephalopathy. Acta Neuropathol 1991;82:229&#x2013;33. 10.1007/BF00294450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00294450</ArticleId><ArticleId IdType="pubmed">1927280</ArticleId></ArticleIdList></Reference><Reference><Citation>Adle-Biassette H, Levy Y, Colombel M, Poron F, Natchev S, Keohane C, et al. Neuronal apoptosis in HIV infection in adults. Neuropathol Appl Neurobiol 1995;21:218&#x2013;27. 10.1111/j.1365-2990.1995.tb01053.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.1995.tb01053.x</ArticleId><ArticleId IdType="pubmed">7477730</ArticleId></ArticleIdList></Reference><Reference><Citation>Adle-Biassette H, Chr&#xe9;tien F, Wingertsmann L, H&#xe9;ry C, Ereau T, Scaravilli F, et al. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 1999;25:123&#x2013;33. 10.1046/j.1365-2990.1999.00167.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2990.1999.00167.x</ArticleId><ArticleId IdType="pubmed">10216000</ArticleId></ArticleIdList></Reference><Reference><Citation>Everall IP, Glass JD, McArthur J, Spargo E, Lantos P. Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia. Acta Neuropathol 1994;88:538&#x2013;44. 10.1007/BF00296490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00296490</ArticleId><ArticleId IdType="pubmed">7879600</ArticleId></ArticleIdList></Reference><Reference><Citation>Everall I, Heaton R, Marcotte T, Ellis R, McCutchan J, Atkinson J, et al. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HIV Neurobehavioral Research Center. Brain Pathol 1999;9:209&#x2013;17. 10.1111/j.1750-3639.1999.tb00219.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.1999.tb00219.x</ArticleId><ArticleId IdType="pmc">PMC8098484</ArticleId><ArticleId IdType="pubmed">10219738</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, et al. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann Neurol 1997;42:963&#x2013;72. 10.1002/ana.410420618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410420618</ArticleId><ArticleId IdType="pubmed">9403489</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA. Spectrum of human immunodeficiency virus&#x2013;associated neocortical damage. Ann Neurol 1992;32:321&#x2013;9. 10.1002/ana.410320304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410320304</ArticleId><ArticleId IdType="pubmed">1416802</ArticleId></ArticleIdList></Reference><Reference><Citation>Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, McArthur JC, et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 1993;34:339&#x2013;50. 10.1002/ana.410340307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410340307</ArticleId><ArticleId IdType="pubmed">7689819</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelman BB, Chen T, Lisinicchia JG, Soukup VM, Carmical JR, Starkey JM, et al. The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS One 2012;7:e46178. 10.1371/journal.pone.0046178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0046178</ArticleId><ArticleId IdType="pmc">PMC3458860</ArticleId><ArticleId IdType="pubmed">23049970</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginsberg SD, Alldred MJ, Gunnam SM, Schiroli C, Lee SH, Morgello S, et al. Expression profiling suggests microglial impairment in human immunodeficiency virus neuropathogenesis. Ann Neurol 2018;83:406&#x2013;17. 10.1002/ana.25160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25160</ArticleId><ArticleId IdType="pmc">PMC5822676</ArticleId><ArticleId IdType="pubmed">29369399</ArticleId></ArticleIdList></Reference><Reference><Citation>Judge M, Parker E, Naniche D, Le Sou&#xeb;f P. Gene expression: the key to understanding HIV-1 infection? Microbiol Mol Biol Rev 2020;84:e00080-19. 10.1128/mmbr.00080-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mmbr.00080-19</ArticleId><ArticleId IdType="pmc">PMC7233484</ArticleId><ArticleId IdType="pubmed">32404327</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna PP, Repunte-Canonigo V, Masliah E, Lefebvre C. Gene expression patterns associated with neurological disease in human HIV infection. PLoS One 2017;12:e0175316. 10.1371/journal.pone.0175316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0175316</ArticleId><ArticleId IdType="pmc">PMC5405951</ArticleId><ArticleId IdType="pubmed">28445538</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon IH, De Girolami U, Chettimada S, Misra V, Singer EJ, Gabuzda D. Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era. BMC Infect Dis 2017;17:151. 10.1186/s12879-017-2246-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-017-2246-7</ArticleId><ArticleId IdType="pmc">PMC5316187</ArticleId><ArticleId IdType="pubmed">28212619</ArticleId></ArticleIdList></Reference><Reference><Citation>Achim CL, Wang R, Miners DK, Wiley CA. Brain viral burden in HIV infection. J Neuropathol Exp Neurol 1994;53:284&#x2013;94. 10.1097/00005072-199405000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199405000-00010</ArticleId><ArticleId IdType="pubmed">8176412</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiley CA, Soontornniyomkij V, Radhakrishnan L, Masliah E, Mellors J, Hermann SA, et al. Distribution of brain HIV load in AIDS. Brain Pathol 1998;8:277&#x2013;84. 10.1111/j.1750-3639.1998.tb00153.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.1998.tb00153.x</ArticleId><ArticleId IdType="pmc">PMC8098236</ArticleId><ArticleId IdType="pubmed">9546286</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson AM, Mu&#xf1;oz-Moreno JA, McClernon DR, Ellis RJ, Cookson D, Clifford DB, et al. Prevalence and correlates of persistent HIV-1 RNA in cerebrospinal fluid during antiretroviral therapy. J Infect Dis 2017;215:105&#x2013;13. 10.1093/INFDIS/JIW505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/INFDIS/JIW505</ArticleId><ArticleId IdType="pmc">PMC5225254</ArticleId><ArticleId IdType="pubmed">27789723</ArticleId></ArticleIdList></Reference><Reference><Citation>Burbelo PD, Price RW, Hagberg L, Hatano H, Spudich S, Deeks SG, et al. Anti-human immunodeficiency virus antibodies in the cerebrospinal fluid: evidence of early treatment impact on central nervous system reservoir? J Infect Dis 2018;217:1024&#x2013;32. 10.1093/infdis/jix662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix662</ArticleId><ArticleId IdType="pmc">PMC5939835</ArticleId><ArticleId IdType="pubmed">29401308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko A, Kang G, Hattler JB, Galadima HI, Zhang J, Li Q, et al. Macrophages but not astrocytes harbor HIV DNA in the brains of HIV-1-infected aviremic individuals on suppressive antiretroviral therapy. J Neuroimmune Pharmacol 2019;14:110&#x2013;9. 10.1007/s11481-018-9809-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-018-9809-2</ArticleId><ArticleId IdType="pmc">PMC6391194</ArticleId><ArticleId IdType="pubmed">30194646</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith DB, Simmonds P, Bell JE. Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users. J Neurovirol 2014;20:28&#x2013;38. 10.1007/s13365-013-0225-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-013-0225-3</ArticleId><ArticleId IdType="pubmed">24420447</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane CR, Angelovich TA, Byrnes SJ, Waring E, Guanizo AC, Trollope GS, et al. Intact HIV proviruses persist in the brain despite viral suppression with ART. Ann Neurol 2022;92:532&#x2013;44. 10.1002/ana.26456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26456</ArticleId><ArticleId IdType="pmc">PMC9489665</ArticleId><ArticleId IdType="pubmed">35867351</ArticleId></ArticleIdList></Reference><Reference><Citation>Desplats P, Dumaop W, Smith D, Adame A, Everall I, Letendre S, et al. Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology 2013;80:1415&#x2013;23. 10.1212/WNL.0b013e31828c2e9e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31828c2e9e</ArticleId><ArticleId IdType="pmc">PMC3662272</ArticleId><ArticleId IdType="pubmed">23486877</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass JD, Wesselingh SL, Selnes OA, McArthur JC. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 1993;43:2230&#x2013;7. 10.1212/wnl.43.11.2230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.43.11.2230</ArticleId><ArticleId IdType="pubmed">8232935</ArticleId></ArticleIdList></Reference><Reference><Citation>An SF, Giometto B, Scaravilli F. HIV-1 DNA in brains in AIDS and pre-AIDS: correlation with the stage of disease. Ann Neurol 1996;40:611&#x2013;7. 10.1002/ana.410400411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410400411</ArticleId><ArticleId IdType="pubmed">8871581</ArticleId></ArticleIdList></Reference><Reference><Citation>Achim CL, Morey MK, Wiley CA. Expression of major histocompatibility complex and HIV antigens within the brains of AIDS patients. AIDS 1991;5:535&#x2013;41. 10.1097/00002030-199105000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002030-199105000-00009</ArticleId><ArticleId IdType="pubmed">1863405</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L, et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992;31:349&#x2013;60. 10.1002/ana.410310402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410310402</ArticleId><ArticleId IdType="pubmed">1586135</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis R, Langford D, Masliah E. HIV and antiretroviral therapy in the brain: Neuronal injury and repair. Nat Rev Neurosci 2007;8:33&#x2013;44. 10.1038/nrn2040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2040</ArticleId><ArticleId IdType="pubmed">17180161</ArticleId></ArticleIdList></Reference><Reference><Citation>Magaki SD, Vinters HV, Williams CK, Mareninov S, Khanlou N, Said J, et al. Neuropathologic findings in elderly HIV-positive individuals. 2022;81:565-76. 10.1093/jnen/nlac040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlac040</ArticleId><ArticleId IdType="pmc">PMC9425852</ArticleId><ArticleId IdType="pubmed">35656871</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho T, Krammer F, Iwasaki A. The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol 2021;21:245&#x2013;56. 10.1038/s41577-021-00522-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00522-1</ArticleId><ArticleId IdType="pmc">PMC7958099</ArticleId><ArticleId IdType="pubmed">33723416</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727&#x2013;33. 10.1056/nejmoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497&#x2013;506. 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, et al. A global database of COVID-19 vaccinations. Nat Hum Behav 2021;5:947&#x2013;53. 10.1038/s41562-021-01122-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-021-01122-8</ArticleId><ArticleId IdType="pubmed">33972767</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinski A, Thompson K, Emanuel E. COVID-19 and excess all-cause mortality in the US and 20 comparison countries, June 2021-March 2022. JAMA 2023;329:92&#x2013;4. 10.1001/jama.2022.21795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.21795</ArticleId><ArticleId IdType="pmc">PMC9856868</ArticleId><ArticleId IdType="pubmed">36399335</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO coronavirus (COVID-19) dashboard. https://covid19.who.int/. Accessed: July 26, 2023.</Citation></Reference><Reference><Citation>Telenti A, Hodcroft EB, Robertson DL. The evolution and biology of SARS-CoV-2 variants. Cold Spring Harb Perspect Med 2022;12:a041390. 10.1101/cshperspect.a041390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a041390</ArticleId><ArticleId IdType="pmc">PMC9159258</ArticleId><ArticleId IdType="pubmed">35444005</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol 2022;23:3&#x2013;20. 10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Esper FP, Adhikari TM, Tu ZJ, Cheng YW, El-Haddad K, Farkas DH, et al. Alpha to Omicron: disease severity and clinical outcomes of major SARS-CoV-2 variants. J Infect Dis 2023;227:344&#x2013;52. 10.1093/infdis/jiac411 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac411</ArticleId><ArticleId IdType="pmc">PMC9619650</ArticleId><ArticleId IdType="pubmed">36214810</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M, Clijsters M, Choi S, Backaert W, Claerhout M, Couvreur F, et al. Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients. Neuron 2022;110:3919-35. 10.1016/j.neuron.2022.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.11.007</ArticleId><ArticleId IdType="pmc">PMC9647025</ArticleId><ArticleId IdType="pubmed">36446381</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M, Yoo SJ, Clijsters M, Backaert W, Vanstapel A, Speleman K, et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell 2021;184:5932-49. 10.1016/j.cell.2021.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.10.027</ArticleId><ArticleId IdType="pmc">PMC8564600</ArticleId><ArticleId IdType="pubmed">34798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol 2022;20:270&#x2013;84. 10.1038/s41579-022-00713-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00713-0</ArticleId><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn JH, Kim JM, Hong SP, Choi SY, Yang MJ, Ju YS, et al. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19. J Clin Invest 2021;131:e148517. 10.1172/JCI148517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI148517</ArticleId><ArticleId IdType="pmc">PMC8245175</ArticleId><ArticleId IdType="pubmed">34003804</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH, et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 2020;182:429-46. 10.1016/j.cell.2020.05.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.042</ArticleId><ArticleId IdType="pmc">PMC7250779</ArticleId><ArticleId IdType="pubmed">32526206</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426:450&#x2013;4. 10.1038/nature02145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02145</ArticleId><ArticleId IdType="pmc">PMC7095016</ArticleId><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270&#x2013;3. 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Millet JK, Jaimes JA, Whittaker GR. Molecular diversity of coronavirus host cell entry receptors. FEMS Microbiol Rev 2021;45:fuaa057. 10.1093/femsre/fuaa057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femsre/fuaa057</ArticleId><ArticleId IdType="pmc">PMC7665467</ArticleId><ArticleId IdType="pubmed">33118022</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020;181:271-80. 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 2020;5:562&#x2013;9. 10.1038/s41564-020-0688-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0688-y</ArticleId><ArticleId IdType="pmc">PMC7095430</ArticleId><ArticleId IdType="pubmed">32094589</ArticleId></ArticleIdList></Reference><Reference><Citation>Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000;87:E1-9. 10.1161/01.res.87.5.e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.res.87.5.e1</ArticleId><ArticleId IdType="pubmed">10969042</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett 2002;532:107&#x2013;10. 10.1016/S0014-5793(02)03640-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(02)03640-2</ArticleId><ArticleId IdType="pubmed">12459472</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikmet F, M&#xe9;ar L, Edvinsson &#xc5;, Micke P, Uhl&#xe9;n M, Lindskog C. The protein expression profile of ACE2 in human tissues. Mol Syst Biol 2020;16:e9610. 10.15252/msb.20209610.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20209610</ArticleId><ArticleId IdType="pmc">PMC7383091</ArticleId><ArticleId IdType="pubmed">32715618</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Wang K, Yu J, Howard D, French L, Chen Z, et al. The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol 2021;11:573095. 10.3389/fneur.2020.573095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.573095</ArticleId><ArticleId IdType="pmc">PMC7855591</ArticleId><ArticleId IdType="pubmed">33551947</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature 2021;595:565&#x2013;71. 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wang Y, Luo W, Huang L, Xiao J, Li F, et al. A comprehensive investigation of the mRNA and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells. Int J Med Sci 2020;17:1522&#x2013;31. 10.7150/ijms.46695.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.46695</ArticleId><ArticleId IdType="pmc">PMC7359402</ArticleId><ArticleId IdType="pubmed">32669955</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004;203:631&#x2013;7. 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuovo GJ, Magro C, Shaffer T, Awad H, Suster D, Mikhail S, et al. Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein. Ann Diagn Pathol 2021;51:151682. 10.1016/j.anndiagpath.2020.151682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anndiagpath.2020.151682</ArticleId><ArticleId IdType="pmc">PMC7758180</ArticleId><ArticleId IdType="pubmed">33360731</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryce C, Grimes Z, Pujadas E, Ahuja S, Beasley MB, Albrecht R, et al. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience. Mod Pathol 2021;34:1456&#x2013;67. 10.1038/s41379-021-00793-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-021-00793-y</ArticleId><ArticleId IdType="pmc">PMC8015313</ArticleId><ArticleId IdType="pubmed">33795830</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocci M, Oudenaarden C, S&#xe0;enz&#x2010;sard&#xe0; X, Simr&#xe9;n J, Ed&#xe9;n A, Sj&#xf6;lund J, et al. Infection of brain pericytes underlying neuropathology of COVID&#x2010;19 patients. Int J Mol Sci 2021;22:11622. 10.3390/ijms222111622.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111622</ArticleId><ArticleId IdType="pmc">PMC8583965</ArticleId><ArticleId IdType="pubmed">34769052</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindskog C, M&#xe9;ar L, Virhammar J, F&#xe4;llmar D, Kumlien E, Hesselager G, et al. Protein expression profile of ACE2 in the normal and COVID-19-affected human brain. J Proteome Res 2022;21:2137&#x2013;45. 10.1021/acs.jproteome.2c00184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.2c00184</ArticleId><ArticleId IdType="pmc">PMC9364976</ArticleId><ArticleId IdType="pubmed">35901083</ArticleId></ArticleIdList></Reference><Reference><Citation>Deigendesch N, Sironi L, Kutza M, Wischnewski S, Fuchs V, Hench J, et al. Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology. Acta Neuropathol 2020;140:583&#x2013;6. 10.1007/s00401-020-02213-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02213-y</ArticleId><ArticleId IdType="pmc">PMC7449525</ArticleId><ArticleId IdType="pubmed">32851506</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683&#x2013;90. 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra S, Kolappa K, Prasad M, Radhakrishnan D, Thakur KT, Solomon T, et al. Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis. Neurology 2021;97:e2269&#x2013;81. 10.1212/WNL.0000000000012930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012930</ArticleId><ArticleId IdType="pmc">PMC8665434</ArticleId><ArticleId IdType="pubmed">34635561</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021;8:416&#x2013;27. 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho SM, White N, Premraj L, Battaglini D, Fanning J, Suen J, et al. Neurological manifestations of COVID-19 in adults and children. Brain 2023;146:1648&#x2013;61. 10.1093/brain/awac332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac332</ArticleId><ArticleId IdType="pmc">PMC9494397</ArticleId><ArticleId IdType="pubmed">36087305</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahjouei S, Tsivgoulis G, Farahmand G, Koza E, Mowla A, Sadr AV, et al. SARS-CoV-2 and stroke characteristics: a report from the multinational COVID-19 stroke study group. Stroke 2021;52:e117&#x2013;30. 10.1161/STROKEAHA.120.032927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.032927</ArticleId><ArticleId IdType="pmc">PMC8078130</ArticleId><ArticleId IdType="pubmed">33878892</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, et al. Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol 2020;77:1366&#x2013;72. 10.1001/jamaneurol.2020.2730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2730</ArticleId><ArticleId IdType="pmc">PMC7333175</ArticleId><ArticleId IdType="pubmed">32614385</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, Fonseca-Rodr&#xed;guez O, Farrington P, Lindmark K, Connolly AMF. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet 2021;398:599&#x2013;607. 10.1016/S0140-6736(21)00896-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00896-5</ArticleId><ArticleId IdType="pmc">PMC8321431</ArticleId><ArticleId IdType="pubmed">34332652</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell CD, Lone NI, Baillie JK. Comorbidities, multimorbidity and COVID-19. Nat Med 2023;29:334&#x2013;43. 10.1038/s41591-022-02156-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02156-9</ArticleId><ArticleId IdType="pubmed">36797482</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. Accessed: November 26, 2023.</Citation></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med 2022;28:2406&#x2013;15. 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Ryan MC, Liang H, Zhang X, Cunningham E, Wang J, et al. Changes in brain activation patterns during working memory tasks in people with post-COVID condition and persistent neuropsychiatric symptoms. Neurology 2023;100:e2409&#x2013;23. 10.1212/WNL.0000000000207309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000207309</ArticleId><ArticleId IdType="pmc">PMC10256123</ArticleId><ArticleId IdType="pubmed">37185175</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina Y, Enose-Akahata Y, Hammoud DA, Videckis AJ, Narpala SR, O&#x2019;Connell SE, et al. Deep phenotyping of neurologic postacute sequelae of SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm 2023;10:e200097. 10.1212/NXI.0000000000200097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000200097</ArticleId><ArticleId IdType="pmc">PMC10162706</ArticleId><ArticleId IdType="pubmed">37147136</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med 2021;27:601&#x2013;15. 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MHB, Wing YK, Yu MWM, Leung CM, Ma RCW, Kong APS, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med 2009;169:2142&#x2013;7. 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T, Mothes R, Heppner FL, Radbruch H. What SARS-CoV-2 does to our brains. Immunity 2022;55:1159&#x2013;72. 10.1016/j.immuni.2022.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.06.013</ArticleId><ArticleId IdType="pmc">PMC9212726</ArticleId><ArticleId IdType="pubmed">35777361</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Sharshar T. Cognitive decline after sepsis. Lancet Respir Med 2015;3:61&#x2013;9. 10.1016/S2213-2600(14)70246-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(14)70246-2</ArticleId><ArticleId IdType="pubmed">25434614</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamar CD, Hurley RA, Taber KH. Sepsis-associated encephalopathy: review of the neuropsychiatric manifestations and cognitive outcome. J Neuropsychiatry Clin Neurosci 2011;23:237&#x2013;41. 10.1176/jnp.23.3.jnp237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/jnp.23.3.jnp237</ArticleId><ArticleId IdType="pubmed">21948885</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021;594:259&#x2013;64. 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Giraldo GS, Ali ST, Kang AK, Patel TR, Budhiraja S, Gaelen JI, et al. Neurologic manifestations of long COVID differ based on acute COVID-19 severity. Ann Neurol 2023;94:146-59. 10.1002/ana.26649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26649</ArticleId><ArticleId IdType="pmc">PMC10724021</ArticleId><ArticleId IdType="pubmed">36966460</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med 2022;28:1461&#x2013;7. 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Afsahi AM, Norbash AM, Syed SF, Sedaghat M, Afsahi G, Shahidi R, et al. Brain MRI findings in neurologically symptomatic COVID-19 patients: a systematic review and meta-analysis. J Neurol 2023;270:5131&#x2013;54. 10.1007/s00415-023-11914-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-023-11914-9</ArticleId><ArticleId IdType="pubmed">37535100</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarty N, Senthilnathan T, Paiola S, Gyani P, Castillo Cario S, Urena E, et al. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis. FEBS Lett 2021;595:2854&#x2013;71. 10.1002/1873-3468.14227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.14227</ArticleId><ArticleId IdType="pmc">PMC8652524</ArticleId><ArticleId IdType="pubmed">34757622</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain 2021;144:1263&#x2013;76. 10.1093/brain/awab009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab009</ArticleId><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazhenets G, Schroeter N, Bormann T, Thurow J, Wagner D, Frings L, et al. Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J Nucl Med 2021;62:910&#x2013;5. 10.2967/jnumed.121.262128.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.262128</ArticleId><ArticleId IdType="pmc">PMC8882885</ArticleId><ArticleId IdType="pubmed">33789937</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 2022;604:697&#x2013;707. 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y, Zhao W, Huang S, Huang C, Li C, Chen Y, et al. Gray matter thickness and subcortical nuclear volume in men after SARS-CoV-2 Omicron infection. JAMA Netw Open 2023;6:e2345626. 10.1001/jamanetworkopen.2023.45626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.45626</ArticleId><ArticleId IdType="pmc">PMC10690469</ArticleId><ArticleId IdType="pubmed">38032639</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez-Cirarda M, Yus M, G&#xf3;mez-Ruiz N, Polidura C, Gil-Mart&#xed;nez L, Delgado-Alonso C, et al. Multimodal neuroimaging in post-COVID syndrome and correlation with cognition. Brain 2023;146:2142&#x2013;52. 10.1093/brain/awac384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac384</ArticleId><ArticleId IdType="pmc">PMC9620345</ArticleId><ArticleId IdType="pubmed">36288544</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon IH, Singh A, Folkerth RD, Mukerji SS. What can we still learn from brain autopsies in COVID-19? Semin Neurol 2023;43:195-204. 10.1055/s-0043-1767716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1767716</ArticleId><ArticleId IdType="pubmed">37023787</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sarraj S, Troakes C, Hanley B, Osborn M, Richardson MP, Hotopf M, et al. Invited review: the spectrum of neuropathology in COVID-19. Neuropathol Appl Neurobiol 2021;47:3&#x2013;16. 10.1111/nan.12667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12667</ArticleId><ArticleId IdType="pubmed">32935873</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebrun L, Absil L, Remmelink M, De Mendon&#xe7;a R, D&#x2019;Haene N, Gaspard N, et al. SARS-Cov-2 infection and neuropathological findings: a report of 18 cases and review of the literature. Acta Neuropathol Commun 2023;11:78. 10.1186/s40478-023-01566-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-023-01566-1</ArticleId><ArticleId IdType="pmc">PMC10170054</ArticleId><ArticleId IdType="pubmed">37165453</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiese A, Manetti AC, Bosetti C, Del Duca F, La Russa R, Frati P, et al. SARS-CoV-2 and the brain: a review of the current knowledge on neuropathology in COVID-19. Brain Pathol 2021;31:e13013. 10.1111/bpa.13013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.13013</ArticleId><ArticleId IdType="pmc">PMC8420197</ArticleId><ArticleId IdType="pubmed">34390282</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosentino G, Todisco M, Hota N, Della Porta G, Morbini P, Tassorelli C, et al. Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: a critical systematic review. Eur J Neurol 2021;28:3856&#x2013;65. 10.1111/ene.15045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15045</ArticleId><ArticleId IdType="pmc">PMC8444743</ArticleId><ArticleId IdType="pubmed">34339563</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur KT, Miller EH, Glendinning MD, Al-Dalahmah O, Banu MA, Boehme AK, et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain 2021;144:2696-708. 10.1093/brain/awab148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab148</ArticleId><ArticleId IdType="pmc">PMC8083258</ArticleId><ArticleId IdType="pubmed">33856027</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon IH, Normandin E, Bhattacharyya S, Mukerji SS, Keller K, Ali AS, et al. Neuropathological features of Covid-19. N Engl J Med 2020;383:989-92. 10.1056/NEJMc2019373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2019373</ArticleId><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou JJ, Movassaghi M, Gordy D, Olson MG, Zhang T, Khurana MS, et al. Neuropathology of COVID-19 (neuro-COVID): clinicopathological update. Free Neuropathol 2021;2:2. 10.17879/freeneuropathology-2021-2993.</Citation><ArticleIdList><ArticleId IdType="doi">10.17879/freeneuropathology-2021-2993</ArticleId><ArticleId IdType="pmc">PMC7861505</ArticleId><ArticleId IdType="pubmed">33554218</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana MF, Frank CHM, Almeida TVR, Jeronimo CMP, de Ara&#xfa;jo Pinto RA, Martins YF, et al. Hemorrhagic and thrombotic manifestations in the central nervous system in COVID-19: a large observational study in the Brazilian Amazon with a complete autopsy series. PLoS One 2021;16:e0255950. 10.1371/journal.pone.0255950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255950</ArticleId><ArticleId IdType="pmc">PMC8432786</ArticleId><ArticleId IdType="pubmed">34506501</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanley B, Naresh KN, Roufosse C, Nicholson AG, Weir J, Cooke GS, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe 2020;1:e245&#x2013;53. 10.1016/S2666-5247(20)30115-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30115-4</ArticleId><ArticleId IdType="pmc">PMC7440861</ArticleId><ArticleId IdType="pubmed">32844161</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaunmuktane Z, Mahadeva U, Green A, Sekhawat V, Barrett NA, Childs L, et al. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19. Acta Neuropathol 2020;140:397&#x2013;400. 10.1007/s00401-020-02190-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02190-2</ArticleId><ArticleId IdType="pmc">PMC7340758</ArticleId><ArticleId IdType="pubmed">32638079</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine A, Lee C, Fava C, Tsang F, Macneil K, Yip ST, et al. Detailed neuropathologic report of COVID-19 complicated by large intracerebral hemorrhage and periventricular lesions with macrophagic infiltrates. Free Neuropathol 2021;2:7. 10.17879/freeneuropathology-2021-3266.</Citation><ArticleIdList><ArticleId IdType="doi">10.17879/freeneuropathology-2021-3266</ArticleId><ArticleId IdType="pmc">PMC10209866</ArticleId><ArticleId IdType="pubmed">37284618</ArticleId></ArticleIdList></Reference><Reference><Citation>El Jamal SM, Pujadas E, Ramos I, Bryce C, Grimes ZM, Amanat F, et al. Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: sustained direct viral-induced damage is not necessary to drive disease progression. Hum Pathol 2021;114:110&#x2013;9. 10.1016/j.humpath.2021.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2021.04.012</ArticleId><ArticleId IdType="pmc">PMC8095022</ArticleId><ArticleId IdType="pubmed">33961839</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri VP, Foschini MP, Lazzarotto T, Gabrielli L, Cenacchi G, Gallo C, et al. Brain ischemic injury in COVID-19-infected patients: a series of 10 post-mortem cases. Brain Pathol 2021;31:205&#x2013;10. 10.1111/bpa.12901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12901</ArticleId><ArticleId IdType="pmc">PMC7536900</ArticleId><ArticleId IdType="pubmed">33002281</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschenbaum D, Imbach LL, Ulrich S, Rushing EJ, Keller E, Reimann RR, et al. Inflammatory olfactory neuropathy in two patients with COVID-19. Lancet 2020;396:166. 10.1016/S0140-6736(20)31525-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31525-7</ArticleId><ArticleId IdType="pmc">PMC7351381</ArticleId><ArticleId IdType="pubmed">32659210</ArticleId></ArticleIdList></Reference><Reference><Citation>Eschbacher KL, Larsen RA, Moyer AM, Majumdar R, Reichard RR. Neuropathological findings in COVID-19: an autopsy cohort. J Neuropathol Exp Neurol 2022;82:21&#x2013;8. 10.1093/jnen/nlac101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlac101</ArticleId><ArticleId IdType="pubmed">36355625</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dalahmah O, Thakur KT, Nordvig AS, Prust ML, Roth W, Lignelli A, et al. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathol Commun 2020;8:147. 10.1186/s40478-020-01024-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01024-2</ArticleId><ArticleId IdType="pmc">PMC7447601</ArticleId><ArticleId IdType="pubmed">32847628</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein JA, Kaes M, Smola S, Schulz-Schaeffer WJ. Neuropathology in COVID-19 autopsies is defined by microglial activation and lesions of the white matter with emphasis in cerebellar and brain stem areas. Front Neurol 2023;14:1229641. 10.3389/fneur.2023.1229641.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1229641</ArticleId><ArticleId IdType="pmc">PMC10374362</ArticleId><ArticleId IdType="pubmed">37521293</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Perl DP, Steiner J, Pasternack N, Li W, Maric D, et al. Neurovascular injury with complement activation and inflammation in COVID-19. Brain 2022;145:2555&#x2013;68. 10.1093/brain/awac151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac151</ArticleId><ArticleId IdType="pmc">PMC9278212</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>Stram MN, Seifert AC, Cortes E, Akyatan A, Woodoff-Leith E, Borukhov V, et al. Neuropathology of pediatric SARS-CoV-2 infection in the forensic setting: novel application of ex vivo imaging in analysis of brain microvasculature. Front Neurol 2022;13:894565. 10.3389/fneur.2022.894565.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.894565</ArticleId><ArticleId IdType="pmc">PMC9170881</ArticleId><ArticleId IdType="pubmed">35685741</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano GE, Walker JE, Tremblay C, Piras IS, Huentelman MJ, Belden CM, et al. SARS-CoV-2 brain regional detection, histopathology, gene expression, and immunomodulatory changes in decedents with COVID-19. J Neuropathol Exp Neurol 2022;81:666&#x2013;95. 10.1093/jnen/nlac056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlac056</ArticleId><ArticleId IdType="pmc">PMC9278252</ArticleId><ArticleId IdType="pubmed">35818336</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurink B, Roos E, Radonic T, Barbe E, Bouman CSC, de Boer HH, et al. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe 2020;1:e290&#x2013;9. 10.1016/S2666-5247(20)30144-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30144-0</ArticleId><ArticleId IdType="pmc">PMC7518879</ArticleId><ArticleId IdType="pubmed">33015653</ArticleId></ArticleIdList></Reference><Reference><Citation>Normandin E, Valizadeh N, Rudmann EA, Uddin R, Dobbins ST, MacInnis BL, et al. Neuropathological features of SARS-CoV-2 delta and Omicron variants. J Neuropathol Exp Neurol 2023;82:283&#x2013;95. 10.1093/jnen/nlad015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlad015</ArticleId><ArticleId IdType="pmc">PMC10025880</ArticleId><ArticleId IdType="pubmed">36847705</ArticleId></ArticleIdList></Reference><Reference><Citation>Wierzba-Bobrowicz T, Krajewski P, Tarka S, Acewicz A, Felczak P, Stepien T, et al. Neuropathological analysis of the brains of fifty-two patients with COVID-19. Folia Neuropathol 2021;59:219&#x2013;31. 10.5114/fn.2021.108829.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/fn.2021.108829</ArticleId><ArticleId IdType="pubmed">34628787</ArticleId></ArticleIdList></Reference><Reference><Citation>Magaki S, Chen Z, Severance A, Williams CK, Diaz R, Fang C, et al. Neuropathology of microbleeds in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). J Neuropathol Exp Neurol 2023;82:333-44. 10.1093/jnen/nlad004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlad004</ArticleId><ArticleId IdType="pmc">PMC10025882</ArticleId><ArticleId IdType="pubmed">36715085</ArticleId></ArticleIdList></Reference><Reference><Citation>Janaway BM, Simpson JE, Hoggard N, Highley JR, Forster G, Drew D, et al. Brain haemosiderin in older people: pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) microbleeds. Neuropathol Appl Neurobiol 2014;40:258&#x2013;69. 10.1111/nan.12062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12062</ArticleId><ArticleId IdType="pmc">PMC4282337</ArticleId><ArticleId IdType="pubmed">23678850</ArticleId></ArticleIdList></Reference><Reference><Citation>Dallaire-Th&#xe9;roux C, Saikali S, Richer M, Potvin O, Duchesne S. Histopathological analysis of cerebrovascular lesions associated with aging. J Neuropathol Exp Neurol 2022;81:97&#x2013;105. 10.1093/jnen/nlab125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlab125</ArticleId><ArticleId IdType="pmc">PMC8801233</ArticleId><ArticleId IdType="pubmed">34875082</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Veluw SJ, Biessels GJ, Klijn CJM, Rozemuller AJM. Heterogeneous histopathology of cortical microbleeds in cerebral amyloid angiopathy. Neurology 2016;86:867&#x2013;71. 10.1212/WNL.0000000000002419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002419</ArticleId><ArticleId IdType="pubmed">26843561</ArticleId></ArticleIdList></Reference><Reference><Citation>McMullen P, Smith H, Pytel P. Entrapped megakaryocytes in the microvasculature of brain tissues are not specific to COVID-19 but can be seen scross a spectrum of acute lung injuries. J Neuropathol Exp Neurol 2021;80:1078&#x2013;80. 10.1093/jnen/nlab048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlab048</ArticleId><ArticleId IdType="pmc">PMC8385991</ArticleId><ArticleId IdType="pubmed">34402517</ArticleId></ArticleIdList></Reference><Reference><Citation>Nauen DW, Hooper JE, Stewart CM, Solomon IH. Assessing brain capillaries in coronavirus disease 2019. JAMA Neurol 2021;78:760-62. 10.1001/jamaneurol.2021.0225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.0225</ArticleId><ArticleId IdType="pmc">PMC7881367</ArticleId><ArticleId IdType="pubmed">33576767</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen MP, Le Quesne J, Officer-Jones L, Teod&#xf2;sio A, Thaventhiran J, Ficken C, et al. Neuropathological findings in two patients with fatal COVID-19. Neuropathol Appl Neurobiol 2021;47:17-25. 10.1111/nan.12662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12662</ArticleId><ArticleId IdType="pubmed">32895961</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichard RR, Kashani KB, Boire NA, Constantopoulos E, Guo Y, Lucchinetti CF. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol 2020;140:1&#x2013;6. 10.1007/s00401-020-02166-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02166-2</ArticleId><ArticleId IdType="pmc">PMC7245994</ArticleId><ArticleId IdType="pubmed">32449057</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker JM, Gilbert AR, Bieniek KF, Richardson TE. COVID-19 patients with CNS complications and neuropathologic features of acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalopathy. J Neuropathol Exp Neurol 2021;80:628&#x2013;31. 10.1093/jnen/nlab036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlab036</ArticleId><ArticleId IdType="pmc">PMC8083297</ArticleId><ArticleId IdType="pubmed">33871008</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK. Acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalitis following COVID-19: systematic review and meta-synthesis. Neurol Neuroimmunol Neuroinflammation 2021;8:e1080. 10.1212/NXI.0000000000001080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001080</ArticleId><ArticleId IdType="pmc">PMC8404207</ArticleId><ArticleId IdType="pubmed">34452974</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantonen J, Mahzabin S, M&#xe4;yr&#xe4;np&#xe4;&#xe4; MI, Tynninen O, Paetau A, Andersson N, et al. Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol 2020;30:1012&#x2013;6. 10.1111/bpa.12889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12889</ArticleId><ArticleId IdType="pmc">PMC7436498</ArticleId><ArticleId IdType="pubmed">32762083</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Perl DP, Nair G, Li W, Maric D, Murray H, et al. Microvascular injury in the brains of patients with Covid-19. N Engl J Med 2021;384:481&#x2013;3. 10.1056/NEJMc2033369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrikaki M, Lee JD, Solomon IH, Slack FJ. Severe COVID-19 is associated with molecular signatures of aging in the human brain. Nat Aging 2022;2:1130&#x2013;7. 10.1038/s43587-022-00321-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-022-00321-w</ArticleId><ArticleId IdType="pubmed">37118539</ArticleId></ArticleIdList></Reference><Reference><Citation>Fullard JF, Lee HC, Voloudakis G, Suo S, Javidfar B, Shao Z, et al. Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19. Genome Med 2021;13:118. 10.1186/s13073-021-00933-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-021-00933-8</ArticleId><ArticleId IdType="pmc">PMC8287557</ArticleId><ArticleId IdType="pubmed">34281603</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A, Peterson JEG, Sandberg G, Takei H, Adesina A, Goodman JC, et al. Central nervous system pathology in fatal swine-origin influenza A H1N1 virus infection in patients with and without neurological symptoms: an autopsy study of 15 cases. Acta Neuropathol 2011;122:371&#x2013;3. 10.1007/s00401-011-0854-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0854-7</ArticleId><ArticleId IdType="pubmed">21744080</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol 2007;170:1136&#x2013;47. 10.2353/ajpath.2007.061088.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2007.061088</ArticleId><ArticleId IdType="pmc">PMC1829448</ArticleId><ArticleId IdType="pubmed">17392154</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J, Gong E, Zhang B, Zheng J, Gao Z, Zhong Y, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med 2005;202:415&#x2013;24. 10.1084/jem.20050828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20050828</ArticleId><ArticleId IdType="pmc">PMC2213088</ArticleId><ArticleId IdType="pubmed">16043521</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Zhong S, Liu J, Li L, Li Y, Wu X, et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin Infect Dis 2005;41:1089&#x2013;96. 10.1086/444461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/444461</ArticleId><ArticleId IdType="pmc">PMC7107994</ArticleId><ArticleId IdType="pubmed">16163626</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau KK, Yu WC, Chu CM, Lau ST, Sheng B, Yuen KY. Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis 2004;10:342&#x2013;4. 10.3201/eid1002.030638.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1002.030638</ArticleId><ArticleId IdType="pmc">PMC3322928</ArticleId><ArticleId IdType="pubmed">15030709</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung EC, Chim SS, Chan PK, Tong YK, Ng EK, Chiu RW, et al. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem 2003;49:2108&#x2013;9. 10.1373/clinchem.2003.025437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2003.025437</ArticleId><ArticleId IdType="pmc">PMC7108123</ArticleId><ArticleId IdType="pubmed">14633896</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis virus transmission pathways. J Pathol 2004;203:622&#x2013;30. 10.1002/path.1560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1560</ArticleId><ArticleId IdType="pmc">PMC7167761</ArticleId><ArticleId IdType="pubmed">15141376</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatnagar J, Gary J, Reagan-Steiner S, Estetter LB, Tong S, Tao Y, et al. Evidence of severe acute respiratory syndrome coronavirus 2 replication and tropism in the lungs, airways, and vascular endothelium of patients with fatal coronavirus disease 2019: an autopsy case series. J Infect Dis 2021;223:752&#x2013;64. 10.1093/infdis/jiab039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab039</ArticleId><ArticleId IdType="pmc">PMC7928839</ArticleId><ArticleId IdType="pubmed">33502471</ArticleId></ArticleIdList></Reference><Reference><Citation>Remmelink M, De Mendon&#xe7;a R, D&#x2019;Haene N, De Clercq S, Verocq C, Lebrun L, et al. Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients. Crit Care 2020;24:495. 10.1186/s13054-020-03218-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03218-5</ArticleId><ArticleId IdType="pmc">PMC7422463</ArticleId><ArticleId IdType="pubmed">32787909</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri VP, Riefolo M, Lazzarotto T, Gabrielli L, Cenacchi G, Gallo C, et al. COVID-19 and the brain: the neuropathological Italian experience on 33 adult autopsies. Biomolecules 2022;12:629. 10.3390/biom12050629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12050629</ArticleId><ArticleId IdType="pmc">PMC9138268</ArticleId><ArticleId IdType="pubmed">35625558</ArticleId></ArticleIdList></Reference><Reference><Citation>Boluda S, Mokhtari K, M&#xe9;garbane B, Annane D, Mathon B, Cao A, et al. Golgi localization of SARS-CoV-2 spike protein and interaction with furin in cerebral COVID-19 microangiopathy: a clue to the central nervous system involvement? Free Neuropathol 2023;4:4-1. 10.17879/freeneuropathology-2023-4584.</Citation><ArticleIdList><ArticleId IdType="doi">10.17879/freeneuropathology-2023-4584</ArticleId><ArticleId IdType="pmc">PMC10240951</ArticleId><ArticleId IdType="pubmed">37283933</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 2021;218:e20202135. 10.1084/JEM.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/JEM.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, Sperhake JP, Schr&#xf6;der AS, Edler C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020;19:919&#x2013;29. 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 2021;24:168&#x2013;75. 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L, Laksono BM, de Vrij FMS, Kushner SA, Harschnitz O, van Riel D. The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2. Trends Neurosci 2022;45:358&#x2013;68. 10.1016/j.tins.2022.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2022.02.006</ArticleId><ArticleId IdType="pmc">PMC8890977</ArticleId><ArticleId IdType="pubmed">35279295</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F, et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med 2021;13:eabf8396. 10.1126/scitranslmed.abf8396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Durrant DM, Ghosh S, Klein RS. The olfactory bulb: an immunosensory effector organ during neurotropic viral infections. ACS Chem Neurosci 2016;7:464&#x2013;9. 10.1021/acschemneuro.6b00043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.6b00043</ArticleId><ArticleId IdType="pmc">PMC5775964</ArticleId><ArticleId IdType="pubmed">27058872</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez G, Tonello C, Osipova G, Carsana L, Biasin M, Cappelletti G, et al. Olfactory bulb SARS-CoV-2 infection is not paralleled by the presence of virus in other central nervous system areas. Neuropathol Appl Neurobiol 2022;48:e12752. 10.1111/nan.12752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12752</ArticleId><ArticleId IdType="pmc">PMC8447476</ArticleId><ArticleId IdType="pubmed">34297438</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, Dittmayer C, von Stillfried S, Meinhardt J, Heinrich F, Hartmann K, et al. Assessing and improving the validity of COVID-19 autopsy studies - a multicentre approach to establish essential standards for immunohistochemical and ultrastructural analyses. EBioMedicine 2022;83:104193. 10.1016/j.ebiom.2022.104193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104193</ArticleId><ArticleId IdType="pmc">PMC9344879</ArticleId><ArticleId IdType="pubmed">35930888</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarius S, Pache F, K&#xf6;rtvelyessy P, Jel&#x10d;i&#x107; I, Stettner M, Franciotta D, et al. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J Neuroinflammation 2022;19:19. 10.1186/s12974-021-02339-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02339-0</ArticleId><ArticleId IdType="pmc">PMC8771621</ArticleId><ArticleId IdType="pubmed">35057809</ArticleId></ArticleIdList></Reference><Reference><Citation>Lersy F, Benotmane I, Helms J, Collange O, Schenck M, Brisset JC, et al. Cerebrospinal fluid features in patients with coronavirus disease 2019 and neurological manifestations: correlation with brain magnetic resonance imaging findings in 58 patients. J Infect Dis 2021;223:600&#x2013;9. 10.1093/infdis/jiaa745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa745</ArticleId><ArticleId IdType="pmc">PMC7798956</ArticleId><ArticleId IdType="pubmed">33249438</ArticleId></ArticleIdList></Reference><Reference><Citation>Destras G, Bal A, Escuret V, Morfin F, Lina B, Josset L. Systematic SARS-CoV-2 screening in cerebrospinal fluid during the COVID-19 pandemic. Lancet Microbe 2020;1:e149. 10.1016/S2666-5247(20)30066-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30066-5</ArticleId><ArticleId IdType="pmc">PMC7289579</ArticleId><ArticleId IdType="pubmed">32835345</ArticleId></ArticleIdList></Reference><Reference><Citation>Ed&#xe9;n A, Grahn A, Bremell D, Aghvanyan A, Bathala P, Fuchs D, et al. Viral antigen and inflammatory biomarkers in cerebrospinal fluid in patients with COVID-19 infection and neurologic symptoms compared with control participants without infection or neurologic symptoms. JAMA Netw Open 2022;5:e2213253. 10.1001/jamanetworkopen.2022.13253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.13253</ArticleId><ArticleId IdType="pmc">PMC9127556</ArticleId><ArticleId IdType="pubmed">35604688</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopfer H, Herzig MC, Gosert R, Menter T, Hench J, Tzankov A, et al. Hunting coronavirus by transmission electron microscopy &#x2013; a guide to SARS-CoV-2-associated ultrastructural pathology in COVID-19 tissues. Histopathology 2021;78:358&#x2013;70. 10.1111/his.14264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/his.14264</ArticleId><ArticleId IdType="pmc">PMC7537546</ArticleId><ArticleId IdType="pubmed">32981112</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsmith CS, Miller SE, Martines RB, Bullock HA, Zaki SR. Electron microscopy of SARS-CoV-2: a challenging task. Lancet 2020;395:e99. 10.1016/S0140-6736(20)31188-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31188-0</ArticleId><ArticleId IdType="pmc">PMC7237172</ArticleId><ArticleId IdType="pubmed">32442529</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullock HA, Goldsmith CS, Zaki SR, Martines RB, Miller SE. Difficulties in differentiating coronaviruses from subcellular structures in human tissues by electron microscopy. Emerg Infect Dis 2021;27:1023&#x2013;31. 10.3201/eid2704.204337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2704.204337</ArticleId><ArticleId IdType="pmc">PMC8007326</ArticleId><ArticleId IdType="pubmed">33600302</ArticleId></ArticleIdList></Reference><Reference><Citation>Xekardaki A, Santos M, Hof P, K&#xf6;vari E, Bouras C, Giannakopoulos P. Neuropathological substrates and structural changes in late-life depression: the impact of vascular burden. Acta Neuropathol 2012;124:453&#x2013;64. 10.1007/s00401-012-1021-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1021-5</ArticleId><ArticleId IdType="pubmed">22836715</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellinger KA. The heterogeneity of late-life depression and its pathobiology: a brain network dysfunction disorder. J Neural Transm 2023;130:1057&#x2013;76. 10.1007/s00702-023-02648-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-023-02648-z</ArticleId><ArticleId IdType="pmc">PMC10162005</ArticleId><ArticleId IdType="pubmed">37145167</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiken S, Sittenfeld L, Dridi H, Liu Y, Liu X, Marks AR. Alzheimer&#x2019;s-like signaling in brains of COVID-19 patients. Alzheimer&#x2019;s Dement 2022;18:955&#x2013;65. 10.1002/alz.12558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12558</ArticleId><ArticleId IdType="pmc">PMC9011576</ArticleId><ArticleId IdType="pubmed">35112786</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, Head E, Schmitt FA, Davis PR, Neltner JH, Jicha GA, et al. Alzheimer&#x2019;s disease is not "brain aging": Neuropathological, genetic, and epidemiological human studies. Acta Neuropathol 2011;121:571&#x2013;87. 10.1007/s00401-011-0826-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0826-y</ArticleId><ArticleId IdType="pmc">PMC3179861</ArticleId><ArticleId IdType="pubmed">21516511</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath S, Levine AJ. HIV-1 infection accelerates age according to the epigenetic clock. J Infect Dis 2015;212:1563&#x2013;73. 10.1093/infdis/jiv277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv277</ArticleId><ArticleId IdType="pmc">PMC4621253</ArticleId><ArticleId IdType="pubmed">25969563</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanlou N, Moore DJ, Chana G, Cherner M, Lazzaretto D, Dawes S, et al. Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. J Neurovirol 2009;15:131&#x2013;8. 10.1080/13550280802578075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280802578075</ArticleId><ArticleId IdType="pmc">PMC3979854</ArticleId><ArticleId IdType="pubmed">19115126</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine A, Sacktor N, Becker JT. Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research. J Neurovirol 2020;26:809&#x2013;23. 10.1007/s13365-020-00897-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00897-2</ArticleId><ArticleId IdType="pmc">PMC7471564</ArticleId><ArticleId IdType="pubmed">32880873</ArticleId></ArticleIdList></Reference><Reference><Citation>Voruz P, Jacot De Alc&#xe2;ntara I, Nuber-Champier A, Cionca A, Allali G, Benzakour L, et al. Frequency of abnormally low neuropsychological scores in post-COVID-19 syndrome: the Geneva COVID-COG Cohort. Arch Clin Neuropsychol 2023;38:1&#x2013;11. 10.1093/arclin/acac068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acac068</ArticleId><ArticleId IdType="pmc">PMC9384624</ArticleId><ArticleId IdType="pubmed">35942646</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch S, Ferrando SJ, Dornbush R, Shahar S, Smiley A, Klepacz L. Screening for brain fog: Is the montreal cognitive assessment an effective screening tool for neurocognitive complaints post-COVID-19? Gen Hosp Psychiatry 2022;78:80&#x2013;6. 10.1016/j.genhosppsych.2022.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2022.07.013</ArticleId><ArticleId IdType="pmc">PMC9359801</ArticleId><ArticleId IdType="pubmed">35930974</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou J, Movassaghi M, Gordy D, Olson M, Singer E, Magaki S, et al. Data elements and tissue procurement for COVID-19 brain banking. J Neuropathol Exp Neurol 2021;80:579&#x2013;80.</Citation></Reference><Reference><Citation>Morgello S, Gelman BB, Kozlowski PB, Vinters HV, Masliah E, Cornford M, et al. The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. 2001;27:326-35. 10.1046/j.0305-1846.2001.00334.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0305-1846.2001.00334.x</ArticleId><ArticleId IdType="pubmed">11532163</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper JE. Rapid autopsy programs and research support: the pre- and post-COVID-19 environments. AJSP Rev Rep 2021;26:100&#x2013;7. .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7954201</ArticleId><ArticleId IdType="pubmed">33718610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Wang L, Yin Y, Yang E. Systematic analysis of gene expression patterns associated with postmortem interval in human tissues. Sci Rep 2017;7:5435. 10.1038/s41598-017-05882-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-05882-0</ArticleId><ArticleId IdType="pmc">PMC5511187</ArticleId><ArticleId IdType="pubmed">28710439</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrobot OA, Attems J, Esiri M, Hortob&#xe1;gyi T, Ironside JW, Kalaria RN, et al. Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. Brain 2016;139:2957-69. 10.1093/brain/aww214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww214</ArticleId><ArticleId IdType="pubmed">27591113</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>